Posters
Presentation Type
Poster
Discipline Track
Patient Care
Abstract Type
Case Report
Abstract
Abstract: Warfarin is a commonly prescribed anticoagulant with a narrow therapeutic window. The prevalence of retroperitoneal hematoma in the general population is not well documented, but it is estimated to be less than 1%. However, the incidence is higher in patients taking anticoagulants such as warfarin, with some studies reporting an incidence as high as 3-6%. Iliopsoas hematoma is reported in literature with frequent non-specific symptoms ranging from abdominal, leg and thigh pain. It is important to recognize them due to the high mortality. This paper aims to demonstrate that patients on warfarin with low hemoglobin and purplish bruises of different sizes should rule out spontaneous hematomas. The purpose of this paper is a reminder for us as physicians that people on warfarin should have close follow-up to avoid complication of supratherapeutic of warfarin.
Recommended Citation
Garcia Cruz, Jian; Perez Rodriguez, Julio; Kondapavuluru, Roy Subash; Abarca Guzman, Oliverio; Chaglasian, Johanne; and Gyebi-Agyepong, Jonathan Yaw, "Spontaneous Iliopsoas Hematoma secondary to Warfarin toxicity" (2024). Research Symposium. 22.
https://scholarworks.utrgv.edu/somrs/2023/posters/22
Included in
Spontaneous Iliopsoas Hematoma secondary to Warfarin toxicity
Abstract: Warfarin is a commonly prescribed anticoagulant with a narrow therapeutic window. The prevalence of retroperitoneal hematoma in the general population is not well documented, but it is estimated to be less than 1%. However, the incidence is higher in patients taking anticoagulants such as warfarin, with some studies reporting an incidence as high as 3-6%. Iliopsoas hematoma is reported in literature with frequent non-specific symptoms ranging from abdominal, leg and thigh pain. It is important to recognize them due to the high mortality. This paper aims to demonstrate that patients on warfarin with low hemoglobin and purplish bruises of different sizes should rule out spontaneous hematomas. The purpose of this paper is a reminder for us as physicians that people on warfarin should have close follow-up to avoid complication of supratherapeutic of warfarin.